SERES THERAPEUTICS INC earnings per share and revenue

1S9 earnings per share for the last quarter are -0.25 EUR whereas the estimation was -0.32 EUR which accounts for 20.98% surprise. Företagets omsättning för samma period uppgår till 0.00 EUR trots den uppskattade siffran 231.70 k EUR. Estimated earnings per share for the next quarter are -0.25 EUR, and revenue is expected to reach -246.32 k EUR. Also watch annual changes over time to get a bigger picture of 1S9 earnings per share and revenue dynamics.